# AbbVie Inc. (ABBV) FY2024 Q3 Balance Sheet

- Company: AbbVie Inc. (ABBV)
- Period: As of 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-11-04, accession number 0001551152-24-000040
- Page: https://plicit.ai/financials/abbv/fy2024-q3-balance-sheet
- Chart image: https://plicit.ai/charts/abbv-fy2024-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 143,422,000,000 US dollars
- **Current assets**: 27,785,000,000 US dollars
- **Non-current assets**: 115,637,000,000 US dollars
- **Liabilities (calculated)**: 137,351,000,000 US dollars
- **Current liabilities**: 43,062,000,000 US dollars
- **Non-current liabilities**: 94,289,000,000 US dollars
- **Equity**: 6,071,000,000 US dollars
- **Noncontrolling interest**: 39,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 11,472,000,000 US dollars
- **Cash and equivalents**: 7,257,000,000 US dollars
- **Prepaid expenses and other**: 4,578,000,000 US dollars
- **Inventories**: 4,450,000,000 US dollars
- **Short-term investments**: 28,000,000 US dollars
- **Intangible assets, net**: 66,646,000,000 US dollars
- **Goodwill**: 35,295,000,000 US dollars
- **Other assets**: 8,288,000,000 US dollars
- **Property and equipment, net**: 5,141,000,000 US dollars
- **Investments**: 267,000,000 US dollars
- **Accounts payable and accrued liabilities**: 30,492,000,000 US dollars
- **Current portion of long-term debt and finance lease obligations**: 12,570,000,000 US dollars
- **Long-term debt and finance lease obligations**: 58,509,000,000 US dollars
- **Other long-term liabilities**: 33,031,000,000 US dollars
- **Deferred income taxes**: 2,749,000,000 US dollars
- **Additional paid-in capital**: 21,160,000,000 US dollars
- **Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,831,415,039 shares issued as of September 30, 2024 and 1,823,046,087 as of December 31, 2023**: 18,000,000 US dollars
- **Noncontrolling interest**: 39,000,000 US dollars
- **Common stock held in treasury, at cost, 64,310,426 shares as of September 30, 2024 and 57,105,354 as of December 31, 2023**: negative 7,848,000,000 US dollars
- **Accumulated deficit**: negative 4,964,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 2,334,000,000 US dollars
- **Gross equity (calculated)**: 21,217,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.